Cathie Wood acquired 18.2 Thousand Regeneron Pharmaceuticals shares worth $16.5 Million. That's 0.13% of their equity portfolio (81st largest holding). The first Regeneron Pharmaceuticals trade was made in Q4 2016. Since then Cathie Wood bought shares nine more times and sold shares on sixteen occasions. The stake costed the investor $9.22 Million, netting the investor a gain of 79% so far.